$5.92
-0.43-6.74%
Last update: Dec 15, 11:52 AM
Comments
Loading...
Edge Rankings
Stock Score Locked: Want to See it?
Benzinga Rankings give you vital metrics on any stock – anytime.
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Exicure (XCUR) stock?
You can purchase shares of Exicure (NASDAQ:XCUR) through any online brokerage.
Who are Exicure (XCUR) competitors?
Other companies in Exicure’s space includes: Serina Therapeutics Inc (AMEX:SER), Kezar Life Sciences Inc (NASDAQ:KZR), Skye Bioscience Inc (NASDAQ:SKYE), FibroGen Inc (NASDAQ:FGEN) and Palatin Technologies Inc (AMEX:PTN).
What is the forecast, or price target, for Exicure (XCUR) stock?
There is no analysis for Exicure to provide a consensus price target.
What is the current price for Exicure (XCUR)?
The stock price for Exicure (NASDAQ: XCUR) is $5.9219 last updated December 15, 2025 at 11:52 AM EST.
Does Exicure (XCUR) pay a dividend?
There are no upcoming dividends for Exicure.
When is Exicure (NASDAQ:XCUR) reporting earnings?
Exicure does not have any upcoming earnings scheduled.
Is Exicure (XCUR) going to split?
There is no upcoming split for Exicure.
What sector and industry does Exicure (XCUR) operate in?
Exicure is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
